Andy Batts
Long only, value, growth, momentum

NuVasive's Innovative Product Launches To Drive Growth, Stock Has Significant Upside

NuVasive (NASDAQ:NUVA) is an innovative player in the spine surgery devices market offering more than 80 unique products. The company's Maximum Access Surgery ("MAS") for lateral spine fusion provides highly differentiated solution with fully integrated nerve monitoring and customizable exposure. The majority of NUVA's revenues are derived from the sale of disposables, implants and fixation devices designed to address a variety of pathologies. I believe that a few of NUVA's recent innovative launches that were named on the "100 Minimally Invasive Orthopedic & Spine Devices to Know" list, such as ALIF ACR, CoRoent XL and XLIF Decade Plate, coupled with its product offerings relating to procedures in the cervical spine as well as in the area...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details